HomeCompareACBD vs JNJ

ACBD vs JNJ: Dividend Comparison 2026

ACBD yields 238.10% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACBD wins by $339.58M in total portfolio value
10 years
ACBD
ACBD
● Live price
238.10%
Share price
$0.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$339.60M
Annual income
$185,958,933.65
Full ACBD calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ACBD vs JNJ

📍 ACBD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACBDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACBD + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACBD pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACBD
Annual income on $10K today (after 15% tax)
$20,238.10/yr
After 10yr DRIP, annual income (after tax)
$158,065,093.60/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ACBD beats the other by $158,064,389.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACBD + JNJ for your $10,000?

ACBD: 50%JNJ: 50%
100% JNJ50/50100% ACBD
Portfolio after 10yr
$169.81M
Annual income
$92,979,880.71/yr
Blended yield
54.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ACBD
No analyst data
Altman Z
-45.0
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACBD buys
0
JNJ buys
0
No recent congressional trades found for ACBD or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACBDJNJ
Forward yield238.10%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$339.60M$20.0K
Annual income after 10y$185,958,933.65$827.78
Total dividends collected$322.91M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ACBD vs JNJ ($10,000, DRIP)

YearACBD PortfolioACBD Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$34,510$23,809.52$10,676$355.77+$23.8KACBD
2$113,715$76,790.22$11,407$389.39+$102.3KACBD
3$358,160$236,484.38$12,198$426.53+$346.0KACBD
4$1,079,339$696,107.48$13,056$467.62+$1.07MACBD
5$3,115,421$1,960,529.07$13,987$513.12+$3.10MACBD
6$8,622,197$5,288,696.04$14,998$563.56+$8.61MACBD
7$22,905,117$13,679,366.22$16,098$619.52+$22.89MACBD
8$58,470,750$33,962,275.23$17,295$681.69+$58.45MACBD
9$143,588,724$81,025,021.41$18,599$750.82+$143.57MACBD
10$339,598,869$185,958,933.65$20,022$827.78+$339.58MACBD

ACBD vs JNJ: Complete Analysis 2026

ACBDStock

Annabidiol Corp. does not have significant operations. Previously, the company was engaged in the telecommunication business. It focuses on the asset acquisitions, strategic partnerships, joint ventures, and partner with companies. The company was formerly known as Asiana Dragons, Inc. and changed its name to Annabidiol Corp. in January 2018. Annabidiol Corp. was incorporated in 2009 and is based in Marblehead, Massachusetts.

Full ACBD Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ACBD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACBD vs SCHDACBD vs JEPIACBD vs OACBD vs KOACBD vs MAINACBD vs ABBVACBD vs MRKACBD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.